These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9031459)

  • 1. Rapid direct determination of low and high molecular weight kininogen in human plasma by Particle Concentration Fluorescence Immunoassay (PCFIA).
    Scott CF; Shull B; Müller-Esterl W; Colman RW
    Thromb Haemost; 1997 Jan; 77(1):109-18. PubMed ID: 9031459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitive antigenic determinations of high molecular weight kininogen performed by covalent coupling of capture antibody.
    Scott CF; Colman RW
    J Lab Clin Med; 1992 Jan; 119(1):77-86. PubMed ID: 1727910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parallel reduction of plasma levels of high and low molecular weight kininogen in patients with cirrhosis.
    Cugno M; Scott CF; Salerno F; Lorenzano E; Müller-Esterl W; Agostoni A; Colman RW
    Thromb Haemost; 1999 Nov; 82(5):1428-32. PubMed ID: 10595632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Commercial immunodepleted deficient plasmas contain cleaved high molecular weight kininogen (HK).
    Mannhalter C; Lang H
    Thromb Haemost; 1988 Dec; 60(3):447-52. PubMed ID: 3238647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of thrombospondin 1 on the surface of activated platelets mediates their interaction with the heavy chains of human kininogens through Lys 244-Pro 254.
    DeLa Cadena RA; Kunapuli SP; Walz DA; Colman RW
    Thromb Haemost; 1998 Jan; 79(1):186-94. PubMed ID: 9459346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of total kininogen deficiency in Japanese patients.
    Ishimaru F; Dansako H; Nakase K; Fujii N; Sezaki N; Nakayama H; Fujii N; Komiyama Y; Iijima K; Takenaka K; Teshima T; Shinagawa K; Ikeda K; Niiya K; Harada M
    Int J Hematol; 1999 Feb; 69(2):126-8. PubMed ID: 10071463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphatidylethanolamine induces specific conformational changes in the kininogens recognizable by antiphosphatidylethanolamine antibodies.
    Sugi T; Mclntyre JA
    Thromb Haemost; 1996 Sep; 76(3):354-60. PubMed ID: 8883270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of clinically significant contact system activation during platelet concentrate filtration by leukocyte removal filters.
    Scott CF; Brandwein H; Whitbread J; Colman RW
    Blood; 1998 Jul; 92(2):616-22. PubMed ID: 9657763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for the presence of a kininogen-like species in a case of total deficiency of low and high molecular weight kininogens.
    Veloso D
    Braz J Med Biol Res; 1998 Jul; 31(7):901-10. PubMed ID: 9698753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights on monoclonal antibodies to kininogens' heavy chain which influence kininogens' binding to platelets.
    Jiang Y; Nawarawong W; Meloni FJ; Schmaier AH
    Thromb Haemost; 1992 Aug; 68(2):143-8. PubMed ID: 1412158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Turnover of human and monkey plasma kininogens in rhesus monkeys.
    Yamada T; Wing DA; Pierce JV; Pettit GW
    J Clin Invest; 1979 Jan; 63(1):45-52. PubMed ID: 105015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational changes in low molecular weight kininogen alters its ability to bind to endothelial cells.
    Hasan AA; Zhang J; Samuel M; Schmaier AH
    Thromb Haemost; 1995 Oct; 74(4):1088-95. PubMed ID: 8560418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunoassay of human high molecular weight kininogen in normal and deficient plasmas.
    Proud D; Pierce JV; Pisano JJ
    J Lab Clin Med; 1980 Apr; 95(4):563-74. PubMed ID: 6153694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Certain autoantibodies to phosphatidylethanolamine (aPE) recognize factor XI and prekallikrein independently or in addition to the kininogens.
    Sugi T; McIntyre JA
    J Autoimmun; 2001 Nov; 17(3):207-14. PubMed ID: 11712858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and partial characterization of a novel form of low molecular weight kininogen from guinea pig plasma.
    Yoshida K; Saito A; Sinohara H
    Biochem Int; 1989 Dec; 19(6):1339-44. PubMed ID: 2635864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low molecular weight kininogen binds to platelets to modulate thrombin-induced platelet activation.
    Meloni FJ; Schmaier AH
    J Biol Chem; 1991 Apr; 266(11):6786-94. PubMed ID: 2016293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet thrombospondin interactions with human high and low molecular weight kininogens.
    DeLa Cadena RA; Wyshock EG; Kunapuli SP; Schultze RL; Miller M; Walz DA; Colman RW
    Thromb Haemost; 1994 Jul; 72(1):125-31. PubMed ID: 7974360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma high molecular weight kininogen concentration in health and in chosen impairments of haemostasis. Evidence that plasmin uncovers a new antigenic site in high molecular weight kininogen.
    Kleniewski J
    Thromb Haemost; 1979 Oct; 42(3):1046-55. PubMed ID: 92069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of the bifunctional properties of high molecular weight kininogen by studies with monoclonal antibodies directed to each of its chains.
    Schmaier AH; Schutsky D; Farber A; Silver LD; Bradford HN; Colman RW
    J Biol Chem; 1987 Jan; 262(3):1405-11. PubMed ID: 2433279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics of the kininogens.
    Schmaier AH; Wahl R; Fisher SJ; Brenner D
    Thromb Res; 1998 Dec; 92(6):293-7. PubMed ID: 9870897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.